FDA

2 statements across 2 episodes · 1 bullish · 1 bearish · 2 people on the record · first statement Nov 13, 2024 by Dr. Mike Israetel · across every show →

Everything said about FDA, oldest first

Nov 13, 2024 bullish

Assertion Partly supported

Israetel: Tirzepatide outperforms Ozempic, with more potent fifth-gen GLP drugs in trials

“Technically it's a third generation GLP drug, but fourth gen is Trisapatide. It's already on the market, Manjaro. Fewer side effects, bigger primary effect. There are fifth gen drugs currently in FDA approval process, which make Ozempic look like a starter pac…”

Dr. Mike Israetel Nov 13, 2024 ▶ 11:40 THIS One Thing All Fit People Know — | Mike Israetel

Dec 11, 2024 negative

Assertion Supported

Saladino: US permits up to 10,000 food chemicals compared to 500 in Europe

“In Europe, there are maybe four to 500 of these chemicals. In the United States, there are five to 10,000.”

Paul Saladino Dec 11, 2024 ▶ 50:57 Everything I Learned In Med School Was WRONG | Paul Saladino

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

FDA

Everything said about FDA, oldest first

Turn any episode into a week of clips.